Session 38

 

Monday, September 4
2:00 – 4:00 pm

Room 18

 

 

Infection and cancer

 

Chairs: Hala El-Zimaity (Canada) – Robert H. Riddell (Canada)

Discussants: Gerardo Nardone (Italy) – Vikash Sewram (South Africa)

 

• What is the normal esophageal microbiota? Is it uniform throughout the esophagus? What is its role in esophageal diseases? Vincenzo Di Pilato (Italy)
• What is the role of Helicobacter in esophageal adenocarcinoma?
• Could controlled gastric Helicobacter infection be used to reduce the incidence of Barrett’s and esophageal adenocarcinoma? Hala El-Zimaity (Canada)
• Does HPV infection result in specific subtypes of esophageal squamous carcinoma.
• By how much are HPV vaccines likely to reduce the risk of esophageal squamous carcinoma? 
  Iva Brcic (Austria)

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

• HPV and adenocarcinoma of the esophagus. Keynote lecture. Shan Rajendra (Australia)     
  
  

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

• What is the role of EBV in esophageal cancer? Rupert Langer & Bastian Dislich (Switzerland)

- what is the biological background of EBV associated gastrointestinal cancer

- what is the impact of EBV in the major types and in rare subtypes of esophageal cancer
   and is there any prognostic or therapeutic relevance?

• Is polyomavirus involved in esophageal carcinogenesis? Monika Tripathi (UK)

• Is JC virus implicated in esophageal carcinoma? Monika Tripathi (UK)
• How does tylosis cause esophageal carcinoma? Maha Guindi (USA)
• Does Barrett’s esophagus predispose to esophageal squamous carcinoma? Maha Guindi (USA)